Qvepen L 75mg/40mg Capsule SR
Marketer
Genostic Pharma Private Limited
Salt Composition
Levosulpiride (75mg) + Pantoprazole (40mg)
Overview Qvepen L 75mg/40mg Capsule SR
Gastroesophageal reflux disease (GERD), or acid reflux, can be managed with Qvepen L 75mg/40mg sustained-release capsules. This medication alleviates symptoms like heartburn, abdominal pain, and irritation by neutralizing stomach acid and facilitating gas expulsion. Dosage and duration are determined by your physician and should be followed precisely. Treatment should continue as prescribed; premature cessation may lead to symptom recurrence and disease exacerbation. Complete disclosure of all other medications to your healthcare provider is crucial, as interactions may occur. Common, usually transient, side effects include nausea, vomiting, diarrhea, headache, fever, rash, abdominal pain, and flatulence. Report any concerning side effects immediately. Dizziness is a potential side effect; avoid driving or activities requiring alertness until its impact is known. Alcohol consumption should be avoided due to potential exacerbation of dizziness. Lifestyle adjustments, such as consuming cold milk and avoiding spicy foods, coffee, tea, and chocolate, may enhance treatment efficacy. Prior to commencing treatment, inform your doctor of any kidney conditions, pregnancy, pregnancy planning, or breastfeeding.
Uses of Qvepen L 75mg/40mg Capsule SR
Managing gastroesophageal reflux disease (GERD)
Major Benefits of Qvepen L 75mg/40mg Capsule SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire Qvepen L 75mg/40mg Capsule SR whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
Common Side effects of Qvepen L 75mg/40mg Capsule SR:
- Stomach pain
- Vomiting
- Diarrhea
- Headache
- Nausea
- Flatulence
- Fundic gland polyps
- Fever
- Skin rash
- Dizziness
How to use Qvepen L 75mg/40mg Capsule SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire capsule without chewing, crushing, or breaking it. Qvepen L 75mg/40mg Sustained-Release Capsules should be taken on an empty stomach.
How Qvepen L 75mg/40mg Capsule SR works:
Levosulpiride and pantoprazole, at 75mg and 40mg respectively, are combined in the sustained-release Qvepen L capsule.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Qvepen L 75mg/40mg sustained-release capsules and alcohol can lead to heightened sleepiness.
PregnancyCONSULT YOUR DOCTOR
The extended-release Qvepen L 75mg/40mg capsule is contraindicated during pregnancy due to confirmed fetal risk. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Medical advice is essential.
Breast feedingUNSAFE
Extended-release Qvepen L 75mg/40mg capsules are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.
DrivingUNSAFE
Driving and operating machinery may be impaired by Qvepen L 75mg/40mg SR Capsules, which can induce drowsiness, dizziness, or movement disorders. Patients should refrain from such activities while taking this medication.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Qvepen L 75mg/40mg sustained-release capsules. Dosage modification for Qvepen L 75mg/40mg sustained-release capsules may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Qvepen L 75mg/40mg sustained-release capsules cautiously, as dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Qvepen L 75mg/40mg Capsule SR :
Should you forget to take a Qvepen L 75mg/40mg Capsule SR, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Qvepen L 75mg/40mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
3,018 People bought this recently